Compare GRML & FOXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | GRML | FOXX |
|---|---|---|
| Founded | N/A | 2017 |
| Country | United States | United States |
| Employees | 5 | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.9M | 34.0M |
| IPO Year | 2022 | N/A |
| Metric | GRML | FOXX |
|---|---|---|
| Price | $0.44 | $5.35 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 3.6M | 12.0K |
| Earning Date | 05-14-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.27 | $1.71 |
| 52 Week High | $0.50 | $8.70 |
| Indicator | GRML | FOXX |
|---|---|---|
| Relative Strength Index (RSI) | 55.80 | 41.73 |
| Support Level | $0.31 | $4.69 |
| Resistance Level | N/A | $4.92 |
| Average True Range (ATR) | 0.06 | 0.47 |
| MACD | 0.01 | -0.10 |
| Stochastic Oscillator | 66.98 | 13.60 |
Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases - cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.
Foxx Development Holdings Inc is a consumer electronics and integrated Internet-of-Things (IoT) solution company catering to both retail and institutional clients. With robust research and development capabilities and a strategic commitment to cultivating long-term partnerships with mobile network operators, distributors, and suppliers. Its products include tablets, smartphones, wearables, and other high-quality communication terminals. The company's current revenue stream is derived from the sales of tablets and smartphones.